It can degrade mucin and reverse increases in fat mass caused by HFD, intra-metabolic toxemia, and insulin resistance, but it also can improve obesity through lipolysis, participation in the synthesis of secondary bile acids, and promotion bile acid metabolism (89–93). The gene discussed is MUC5AC; the disease is obesity disorder.